BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salama L, Pastor ER, Stone T, Mousa SA. Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management. Biomedicines 2020;8:E347. [PMID: 32932737 DOI: 10.3390/biomedicines8090347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kamat S, Kumari M, Sajna KV, Shruthi Mohan, Jayabaskaran C. Marine endophytes from the Indian coasts: The untapped sources of sustainable anticancer drug discovery. Sustainable Chemistry and Pharmacy 2022;27:100675. [DOI: 10.1016/j.scp.2022.100675] [Reference Citation Analysis]
2 Kashyap VK, Peasah-darkwah G, Dhasmana A, Jaggi M, Yallapu MM, Chauhan SC. Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics. Pharmaceutics 2022;14:611. [DOI: 10.3390/pharmaceutics14030611] [Reference Citation Analysis]
3 Huang W, Xing Y, Zhu L, Zhuo J, Cai M. Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2. Exp Cell Res 2021;406:112633. [PMID: 34089726 DOI: 10.1016/j.yexcr.2021.112633] [Reference Citation Analysis]
4 Chen KJ, Plaunt AJ, Leifer FG, Kang JY, Cipolla D. Recent advances in prodrug-based nanoparticle therapeutics. Eur J Pharm Biopharm 2021;165:219-43. [PMID: 33979661 DOI: 10.1016/j.ejpb.2021.04.025] [Reference Citation Analysis]
5 Gupta S, Tejavath KK. Nano Phytoceuticals: A Step Forward in Tracking Down Paths for Therapy Against Pancreatic Ductal Adenocarcinoma. J Clust Sci. [DOI: 10.1007/s10876-021-02213-2] [Reference Citation Analysis]
6 Sitia L, Bonizzi A, Mazzucchelli S, Negri S, Sottani C, Grignani E, Rizzuto MA, Prosperi D, Sorrentino L, Morasso C, Allevi R, Sevieri M, Silva F, Truffi M, Corsi F. Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax. Cells 2021;10:328. [PMID: 33562504 DOI: 10.3390/cells10020328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Pillai SC, Borah A, Jacob EM, Kumar DS. Nanotechnological approach to delivering nutraceuticals as promising drug candidates for the treatment of atherosclerosis. Drug Deliv 2021;28:550-68. [PMID: 33703990 DOI: 10.1080/10717544.2021.1892241] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zielińska A, Szalata M, Gorczyński A, Karczewski J, Eder P, Severino P, Cabeda JM, Souto EB, Słomski R. Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications. Cancers (Basel) 2021;13:1896. [PMID: 33920840 DOI: 10.3390/cancers13081896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]